Industry News
Scientists comment on proposed GM moratorium in South Australia
Leading South Australian agricultural scientists are alarmed by a proposed Bill by South Australian Democrat Ian Gilfillan to place a five-year moratorium on GMOs in South Australia. [ + ]
Australian Animal Health Laboratory director appointed
CSIRO has appointed Dr Martyn Jeggo, international expert on livestock disease detection and control, as the new director of the Australian Animal Health Laboratory in Geelong. [ + ]
New Burnet head to research edible vaccine research
An edible vaccine project is among the research programs to be introduced by incoming Burnet Institute director Prof Steven Wesselingh. [ + ]
CSL subsidiary strikes agreement with Novartis
CSL's Swiss subsidiary has struck a deal with drug company Novartis over the marketing and distribution of its intravenous immunoglobulin product. [ + ]
Proteomics facility opens at Bio21
Victorian Innovation Minister John Brumby officially opened a $12 million proteomics facility within the Bio21 precinct at Parkville today. [ + ]
Ambri appoints business development manager
Biosensor developer Ambri has appointed a new business development manager to drive sales of its SensiDx System throughout the Asia Pacific region. [ + ]
Brisbane start-up Protagonist aims for more of a leading role
Drug design start-up Protagonist is attempting to move up the food chain from a tools-oriented company to one with a proprietary interest in the molecules it designs and synthesises. [ + ]
New UQ research complex
A new research complex, the Centres for Health Research, was officially opened on Monday at the Princess Alexandra Hospital to house 140 scientists from the University of Queensland and the Princess Alexandra Hospital. [ + ]
Bio conference success: it's all in the planning
A post-Bio 2002 debriefing session organised by AusBiotech and the BioMelbourne Network this week had one big message for future delegations - planning, planning, planning. [ + ]
CBio bucks trend, achieves 'satisfactory' capital raising
Brisbane biotech CBio is set to conclude an 11-month, $5 million capital raising that coincided with the worst investor environment in a decade. [ + ]
Diatranz denies trans-Tasman plans
A New Zealand company working on a pig-derived cure for type 1 diabetes has denied reports of a planned move to Australia. [ + ]
New Australian group in kidney bioengineering push
A consortium of Australia's top kidney scientists has come together with the ambitious goal of using stem cells to engineer a bioartificial organ. [ + ]
New director for Ventracor
Artificial heart device developer Ventracor has appointed a new director to its ranks. [ + ]
Red tape hampering Sirtex at home
The US is embracing Sirtex Medical's novel anti-cancer technology more quickly than Australia where government evaluation of the technology appears to have stalled. [ + ]
Developing nanosensors for astronauts
Along with space suits, freeze-dried food and barf bags, tomorrow's astronauts may travel with nanomolecular devices inside their white blood cells to detect early signs of damage from dangerous radiation or infection.
[ + ]
